Point72 Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-85,414
| Closed | -$29.7M | – | 2885 |
|
|
2023
Q3 | $29.7M | Sell |
85,414
-161,025
| -65% | -$56.3M | 0.09% | 305 |
|
|
2023
Q2 | $86.7M | Sell |
246,439
-12,061
| -5% | -$4.06M | 0.26% | 97 |
|
|
2023
Q1 | $81.4M | Buy |
258,500
+147,661
| +133% | +$44.3M | 0.25% | 94 |
|
|
2022
Q4 | $32M | Buy |
110,839
+3,439
| +3% | +$1.05M | 0.11% | 240 |
|
|
2022
Q3 | $31.1M | Buy |
+107,400
| New | +$30.9M | 0.12% | 219 |
|
|
2022
Q1 | – | Sell |
-47,600
| Closed | -$10.5M | – | 1411 |
|
|
2021
Q4 | $10.5M | Buy |
+47,600
| New | +$9.26M | 0.04% | 501 |
|
|
2021
Q3 | – | Sell |
-66,500
| Closed | -$13.4M | – | 1258 |
|
|
2021
Q2 | $13.4M | Sell |
66,500
-597,473
| -90% | -$125M | 0.06% | 382 |
|
|
2021
Q1 | $143M | Buy |
663,973
+440,873
| +198% | +$96.8M | 0.67% | 18 |
|
|
2020
Q4 | $52.7M | Buy |
223,100
+92,900
| +71% | +$21.3M | 0.26% | 87 |
|
|
2020
Q3 | $35.4M | Buy |
+130,200
| New | +$35.9M | 0.18% | 149 |
|
|
2020
Q1 | – | Sell |
-114,821
| Closed | -$25.1M | – | 1107 |
|
|
2019
Q4 | $25.1M | Sell |
114,821
-80,490
| -41% | -$16.3M | 0.13% | 220 |
|
|
2019
Q3 | $33.1M | Buy |
195,311
+77,939
| +66% | +$13.8M | 0.2% | 143 |
|
|
2019
Q2 | $21.5M | Buy |
117,372
+6,654
| +6% | +$1.16M | 0.11% | 226 |
|
|
2019
Q1 | $20.4M | Buy |
110,718
+42,518
| +62% | +$7.85M | 0.09% | 244 |
|
|
2018
Q4 | $11.3M | Sell |
68,200
-34,700
| -34% | -$6.01M | 0.06% | 389 |
|
|
2018
Q3 | $19.8M | Sell |
102,900
-241,915
| -70% | -$43.1M | 0.08% | 303 |
|
|
2018
Q2 | $58.6M | Buy |
344,815
+314,815
| +1,049% | +$48.8M | 0.23% | 124 |
|
|
2018
Q1 | $4.89M | Sell |
30,000
-679,817
| -96% | -$111M | 0.02% | 579 |
|
|
2017
Q4 | $106M | Sell |
709,817
-199,413
| -22% | -$29.5M | 0.46% | 42 |
|
|
2017
Q3 | $138M | Buy |
909,230
+898,089
| +8,061% | +$135M | 0.62% | 28 |
|
|
2017
Q2 | $1.44M | Sell |
11,141
-260,522
| -96% | -$31.4M | 0.01% | 698 |
|
|
2017
Q1 | $29.7M | Sell |
271,663
-615,337
| -69% | -$54.2M | 0.17% | 163 |
|
|
2016
Q4 | $65.3M | Buy |
+887,000
| New | +$72.2M | 0.46% | 49 |
|
|
2016
Q2 | – | Sell |
-838,700
| Closed | -$66.7M | – | 893 |
|
|
2016
Q1 | $66.7M | Buy |
+838,700
| New | +$75.9M | 0.51% | 37 |
|
|
2015
Q4 | – | Sell |
-15,000
| Closed | -$1.56M | – | 864 |
|
|
2015
Q3 | $1.56M | Buy |
+15,000
| New | +$1.93M | 0.01% | 588 |
|
|
2015
Q2 | – | Sell |
-29,200
| Closed | -$3.44M | – | 861 |
|
|
2015
Q1 | $3.44M | Buy |
29,200
+12,700
| +77% | +$1.52M | 0.02% | 499 |
|
|
2014
Q4 | $1.96M | Sell |
16,500
-426,800
| -96% | -$48.1M | 0.01% | 550 |
|
|
2014
Q3 | $49.8M | Sell |
443,300
-491,400
| -53% | -$46.8M | 0.37% | 63 |
|
|
2014
Q2 | $88.5M | Buy |
+934,700
| New | +$65.5M | 0.57% | 31 |
|
Other funds holding VRTX
VCM
VPM
Point72 Asset Management's VRTX Position: Q4 2023 in Review
Point72 Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2023, closing a stake of 85,414 shares — an estimated $29.7M sold.
Point72 Asset Management first reported a position in VRTX in Q2 2014 and held it in 29 quarters. The position peaked at $143M in Q1 2021. 1,438 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.
- Point72 Asset Management reported no remaining Vertex Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Point72 Asset Management sold 85,414 Vertex Pharmaceuticals shares in Q4 2023, an estimated $29.7M.
- Point72 Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2014 and held it in 29 quarters.
- Point72 Asset Management's Vertex Pharmaceuticals position peaked at $143M in Q1 2021.
- 1,438 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.
Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.